Cetuximab Biosimilar - Research Grade,ichor.bio,ICH4004

Detects human EGFR. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Cetuximab.

Host

Humanized

Reactivity

Human

Platform ID

BAB510076868

ichor.bio

Headquarters

Grove Business Park Downsview Road Wantage OX12 9FF

Contact

Tel:
Fax:

Product Specifications
Scientific Background
Synonyms

Specifications

NameCetuximab Biosimilar - Research Grade
Cat. No.ICH4004
Accession NumberP00533
HostHumanized
IsotypeHuman IgG1
ReactivityHuman
Concentration1.0 - 5.0 mg/ml
TargetEGFR
Purity>95% by SDS-PAGE and HPLC
Endotoxin Level≤ 1.0 EU/mg as determined by the LAL method
ShippingBlue ice
FormulationICH3001-100ml ICH3002-100ml ICH3003-100ml
StorageStable for at least one week when stored sterile at 2-8°C. For long term storage aseptically aliquot in working volumes without diluting and store at -80°C. Avoid Repeated Freeze Thaw Cycles.
Regulatory StatusFor research use only

Scientific Background

Cetuximab biosimilar is a recombinant, human/mouse chimeric monoclonal antibody that binds specifically to the extracellular domain of the human epidermal growth factor receptor (EGFR). Cetuximab biosimilar is composed of the Fv regions of a murine anti-E

Synonyms

Epidermal growth factor receptor, Proto-oncogene c-ErbB-1, Receptor tyrosine-protein kinase erbB-1, ERBB, ERBB1, HER1

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.